22 research outputs found
Effect of peptide-based caspase inhibitors on SKNAS cells as determined using the Caspase-GloĀ® 6 assay.
<p>SKNAS cells were treated with Ac-VEID-CHO (ā¢) or Ac-DEVD-CHO (āŖ) prior to addition of 3 ĀµM staurosporine for 6 hours and detection of VEID-ase activity as described in Experimental Procedures. Concentration inhibition curves were performed in duplicate and represent 1 of at least 3 experiments with similar results. Concentration-response curves for each inhibitor were normalized to zero and 100% based on no staurosporine or DMSO, respectively. The mean and standard error of the mean are reported.</p
Comparison of potency of peptide-derived caspase inhibitors in cellular lamin cleavage assay, enzymatic activity and cell permeability.
<p>ndā=ānot determined</p><p>aā=āz-VEID-TFPM enzymatic IC<sub>50</sub> is less than 0.0017 due to limit of enzymatic assay detection.</p><p>*Enzymatic IC<sub>50</sub> values were determined after a 15 minute enzyme/inhibitor preincubation and 40 minute enzyme reaction.</p
Effect of peptide-based caspase inhibitors on the generation of cleaved lamin A/C in SKNAS cells.
<p>(A) SKNAS cells were treated with z-VEID-FMK (ā¦), z-DEVD-FMK (āŖ), Q-VD-OPh (ā¢), Ac-VEID-CHO (ā“) or Ac-DEVD-CHO (ā) prior to addition of 3 ĀµM staurosporine for 6 hours. (B) SKNAS cells were treated with z-ID-TFPM (ā¢), z-EID-TFPM (ā“) or z-VEID-TFPM (āŖ) prior to addition of 3 ĀµM staurosporine for 6 hours. Detection of the small lamin A/C cleavage product was performed as described in Experimental Procedures. Concentration inhibition curves were performed in duplicate and represent 1 of at least 3 experiments with similar results. Concentration-response curves for each inhibitor were normalized to zero and 100% based on no staurosporine or DMSO, respectively. The mean and standard error of the mean are reported.</p
Apoptosis-mediated cleavage of lamin A/C is elevated in wild-type relative to caspase-6 KO fibroblasts.
<p>Fibroblasts derived from caspase-6 KO (āŖ) or wild type (ā¢) mice were treated with the indicated concentration of staurosporine for 6 hours prior to detection of the small lamin A/C cleavage product. The assay was performed in quadruplicate two times with similar results; mean and standard error of the mean are reported.</p
Potency of peptide-derived caspase inhibitors possessing aldehyde (CHO) and fluoromethyl ketone (FMK) warheads against executioner caspases.
<p>*IC<sub>50</sub> values were determined after a 15 minute enzyme/inhibitor preincubation and 40 minute enzyme reaction. Due to the capacity for time-dependent inhibition with irreversible inhibitors the values reported can be considered āapparent IC<sub>50</sub>ā.</p
Effect of staurosporine on the generation of cleaved lamin A/C in SKNAS cells.
<p>SKNAS cells were treated with the indicated concentration of staurosporine for 6 hours prior to detection of the small lamin A/C cleavage product as described in Experimental Procedures. The assay was performed in triplicate one time. The mean and standard error of the mean are reported.</p
Western blot detection of lamin A/C from SKNAS neuroblastoma cells upon staurosporine treatment.
<p>(A) Schematic of the N- and C-terminal globular domains of Lamin A/C with VEID-containing central Ī±-helical region as the site of caspase-6 proteolysis. (B) SKNAS cells were treated with DMSO control or staurosporine for 6 hours prior to cell lysis. Lysates were probed for small lamin A/C subunit (Lanes 1ā2), large lamin A/C subunit (Lanes 3ā4) or total lamin A/C (Lanes 5ā6). (C) SKNAS cells were treated with DMSO or staurosporine for the indicated time prior to cell lysis. Lysates were probed for large lamin A/C subunit (red) or Ī²-Actin (green).</p
Western blot detection of recombinant GST-lamin A processing by purified caspases.
<p>(A) The indicated concentration of caspase-6 was incubated with GST-lamin A for two hours. (B) 300 Units of caspases 1ā9 were incubated with GST-lamin A for two hours. Intact and cleaved lamin A were detected via western blotting using anti-GST antibody.</p
Effect of staurosporine on the release of Lactate Dehydrogenase in SKNAS cells.
<p>SKNAS cells were treated with the indicated concentration of staurosporine for 2 (ā¢), 4 (āŖ), 6 (ā“) or 8 (ā¦) hours prior to detection of LDH release to the cell supernatant. The assay was performed in triplicate and represents 1 of at least 2 experiments with similar results. The data was normalized to fold increase over DMSO treatment. The mean and standard error of the mean are reported.</p
Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques
USP7
is a deubiquitinase implicated in destabilizing the tumor
suppressor p53, and for this reason it has gained increasing attention
as a potential oncology target for small molecule inhibitors. Herein
we describe the biophysical, biochemical, and computational approaches
that led to the identification of 4-(2-aminopyridin-3-yl)Āphenol compounds
described by Kategaya (Nature 2017, 550, 534ā538) as specific inhibitors of
USP7. Fragment based lead discovery (FBLD) by NMR combined with virtual
screening and re-mining of biochemical high-throughput screening (HTS)
hits led to the discovery of a series of ligands that bind in the
āpalmā region of the catalytic domain of USP7 and inhibit
its catalytic activity. These ligands were then optimized by structure-based
design to yield cell-active molecules with reasonable physical properties.
This discovery process not only involved multiple techniques working
in concert but also illustrated a unique way in which hits from orthogonal
screening approaches complemented each other for lead identification